Global Cardiopulmonary Stress Testing Systems Market Driven by Increasing Prevalence of Coronary Artery Disease

The global cardiopulmonary stress testing systems market will exhibit a notable CAGR of 8.20% during the forecast period from 2015 to 2023, says Transparency Market Research (TMR). In 2014, the global cardiopulmonary stress testing systems market was worth US$3.3 bn and by 2023, the market is projected to double in value and be worth US$6.6 bn. The dynamics of the global cardiopulmonary stress testing systems market are shaped by several drivers and restraints. Here are the top 5 trends that will impact the global cardiopulmonary stress testing systems market in the foreseeable future.


5 Key Trends Shaping the Global Cardiopulmonary Stress Testing Systems Market

Increasing Prevalence of Coronary Artery Disease: Coronary artery disease (CAD) is considered the most common type of heart disease and is a leading cause of death in the U.S. in both women and men. The prevalence of CAD is rising globally, which will drive the global cardiopulmonary stress testing systems market significantly in the coming few years. According to the WHO, around 17.5 mn people died from cardiovascular diseases in 2012, amounting to 31% of global deaths and out of these 7.4 mn were caused by coronary heart disease.
Rising Obesity Rate: According to the CDC, over one-third of adults in the U.S. are obese. Heart disease is one of the major obesity-related conditions. The growing rate of obesity in the world is projected to drive the global cardiopulmonary stress testing systems market substantially in the coming few years.
New Technologies: The global cardiopulmonary stress testing systems market will benefit from advancements in technology. The penetration of new monitoring technologies in the market is greatly improving the diagnosis rate. 
Implementation of Legal Provisions: Although the global cardiopulmonary stress testing systems market will expand significantly during the forecast period, it will be suppressed by the implementation of legal provisions such as the Affordable Care Act, promoting cost cutting strategies. The global cardiopulmonary stress testing systems market will also be restrained by the slow growth in the number of SPECT MPI procedures.
Opportunities in Emerging Nations: Players in the global cardiopulmonary stress testing systems market will benefit from the huge growth potential on offer in emerging markets around the world. China and India are two of the most promising markets for cardiopulmonary stress testing systems. The cardiopulmonary stress testing systems market in the APAC region is projected to progress at the highest CAGR during the forecast period. In addition to this, Brazil and Mexico in the Latin America cardiopulmonary stress testing systems market will witness strong growth in the aforementioned forecast period.


Some of the players operating in multiple avenues in the global cardiopulmonary stress testing systems market are CareFusion Corporation, Philips Healthcare, Spacelabs Healthcare, and GE Healthcare. Other notable players operating in the global cardiopulmonary stress testing systems market are COSMED, Nihon Kohden Corporation, MGC Diagnostic Corporation, SunTech Medical, and Schiller.

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports